Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06710379 · ClinicalTrials.gov registry record · Phase 1

A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors

A Phase 1 study of Solid Tumors, sponsored by Adcentrx Therapeutics.

Recruiting
Registry status
Phase 1
Development phase
68
Enrollment target
8
Study locations

NCT06710379 is a Phase 1 study of Solid Tumors that is actively recruiting participants, run by Adcentrx Therapeutics. The registered enrollment target is 68 participants, below the 284-participant average among 125 other Solid Tumors trials with a reported enrollment target (76% lower). The trial reports 8 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06710379, a Phase 1 study of Solid Tumors, is actively recruiting participants, sponsored by Adcentrx Therapeutics.

RECRUITING
Registry status
Phase 1
Development phase
68 participants
Enrollment target
8
Study locations

Study Summary

The primary purpose of this study is to assess the safety, tolerability, and pharmacokinetics, and to identify the optimal dose of ADRX-0405 in patients with select advanced solid tumors.

Conditions Studied

Solid Tumors

Interventions

  • DRUG ADRX-0405

Study Locations (8)

California

  • City of Hope - Duarte
  • UCLA - Santa Monica

Texas

  • NEXT Austin - Austin
  • The University of Texas MD Anderson Cancer Center - Houston

Michigan

  • START Midwest - Grand Rapids

Minnesota

  • University of Minnesota Masonic Cancer Center - Minneapolis

Utah

  • START Mountain Region - West Valley City

Virginia

  • NEXT Virginia - Fairfax

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2024-12-30
Est. Completion 2026-12
Phase Phase 1

Sponsor

Adcentrx Therapeutics

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06710379

The ClinicalTrials.gov registry entry for NCT06710379 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 284-participant average among 125 other Solid Tumors trials with a reported enrollment target (76% lower). The listed sponsor is Adcentrx Therapeutics, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Solid Tumors appearing as the primary indexed condition, and to 1 intervention - of which ADRX-0405 is the first listed.

NCT06710379 reports 8 study locations spanning 6 distinct geographic areas - top geographies include California, Texas, Michigan.

Frequently Asked Questions

What is clinical trial NCT06710379 about?

NCT06710379 is a clinical study titled "A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors". The primary purpose of this study is to assess the safety, tolerability, and pharmacokinetics, and to identify the optimal dose of ADRX-0405 in patients with select advanced solid tumors.

What is the current status of trial NCT06710379?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 68 participants. The study started on 2024-12-30. Estimated completion is 2026-12.

What conditions does trial NCT06710379 study?

This clinical trial studies the following conditions: Solid Tumors.

What interventions are being tested in trial NCT06710379?

The interventions under investigation include: ADRX-0405 (DRUG).

Who is sponsoring clinical trial NCT06710379?

This trial is sponsored by Adcentrx Therapeutics, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06710379 being conducted?

This trial has 8 study locations across California, Michigan, Minnesota, Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Solid Tumors

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Solid Tumors

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.